Assistance Fund: Psoriatic Arthritis
Not Funded
About
The Assistance Fund: Psoriatic Arthritis program offers substantial benefits for patients prescribed FDA-approved treatments, such as Cimzia, Humira, and others, to manage psoriatic arthritis. This program provides financial assistance for copays, deductibles, and other out-of-pocket medical expenses, ensuring that qualified patients receive essential drugs like Stelara and Xeljanz. With the Assistance Fund: Psoriatic Arthritis program, eligible U.S. citizens or permanent residents can access necessary treatments while alleviating financial burdens.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
Assistance Fund: Psoriatic Arthritis
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Please note the following:
•1. Copay grant programs provide assistance for copays, coinsurance, and deductibles for FDAapproved treatment for the disease named in the disease program ONLY
•2. Financial assistance grant programs provide assistance for other eligible outofpocket costs, such as health insurance premiums and incidental medical expenses, in addition to copay, coinsurance, and deductible assistance on FDAapproved treatment for the disease named in the disease program
•3. This fund may cover offlabel drugs
•Copay and Financial assistance can be utilized by any innetwork pharmacy or site of care able to dispense the medication or provide treatment
•Program offers conditional approval of 30 days of immediate assistance for open programs where funding is available
•Patients will be asked to provide and verify demographic, insurance, and financial information (additional documentation may be requested)
•Approved patients will be granted assistance through the end of the calendar year unless otherwise specified for the applicable program
Enrollment Forms
Enrollment Form
Other Programs